Skip to content

Schering-Plough SGP Lease Liability Payments - Due After Year Five

Lease Liability Payments - Due After Year Five at other companies

Tarsus Pharmaceuticals, Inc. logo
Tarsus Pharmaceuticals, Inc.TARS
$15.4M

Other financials

Income statement

See full
Operating income-$15.4M-108%
Net income-$13.8M-56.6%
EPS (diluted)-$0.69+82.6%

Balance sheet

See full
Cash & equivalents$238.9M+312%
Total debt$1.6M
Total equity$250.1M+463%
Total assets$258.4M

Cash flow

See full
Operating cash flow-$13.5M-65.2%
CapEx$676.0K+312%
Free cash flow-$14.2M-70.0%

Valuation

See full
Market cap$722.83M-13.5%
Enterprise value$485.53M

Returns & leverage

See full
Return on equity-34.3%
Debt / equity
Current ratio38×

Where this comes from

Reported directly by Schering-Plough in its filing.

Tagged under the XBRL concept us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive.

The official record: Schering-Plough’s 10-K, filed March 26, 2026, on SEC EDGAR. View the filing →

Ask your AI about Schering-Plough's lease liability payments - due after year five.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Schering-Plough's lease liability payments - due after year five?
Schering-Plough (SGP) reported lease liability payments - due after year five of $2M in Q4 2025.
What does lease liability payments - due after year five mean?
Represents the total undiscounted future cash outflows required for operating and finance lease obligations beyond a five-year horizon. This metric provides visibility into long-term fixed occupancy and equipment costs, which are critical for assessing structural overhead and long-term solvency.